Abbonarsi

National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010 - 10/12/14

Doi : 10.1016/j.ahj.2014.06.011 
Yun Wang, PhD a, b, Judith H. Lichtman, PhD, MPH c, Kumar Dharmarajan, MD, MBA a, d, Frederick A. Masoudi, MD, MSPH e, Joseph S. Ross, MD, MHS a, f, g, John A. Dodson, MD h, Jersey Chen, MD, MPH i, John A. Spertus, MD, MPH j, Sarwat I. Chaudhry, MD f, Brahmajee K. Nallamothu, MD, MPH k, Harlan M. Krumholz, MD, SM a, g, l, m,
a Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT 
b Department of Biostatistics, Harvard School of Public Health, Boston, MA 
c Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT 
d (During the time the work was conducted) Division of Cardiology, Columbia University Medical Center, New York, NY 
e University of Colorado Anschutz Medical Campus, Aurora, CO 
f Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 
g Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 
h (During the time the work was conducted) Division of Aging, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 
i Kaiser Permanente Mid-Atlantic Permanente Research Institute, Rockville, MD 
j St Luke’s Mid America Heart Institute and University of Missouri–Kansas City, Kansas City, MO 
k Ann Arbor VA Center for Clinical Management and Research and University of Michigan Health System, Ann Arbor, MI 
l Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 
m Department of Health Policy and Management, Yale School of Public Health, New Haven, CT 

Reprint requests: Harlan M. Krumholz, MD, SM, Yale University School of Medicine, 1 Church St, Suite 200, New Haven, CT 06510.

Riassunto

Background

Stroke is a common and important adverse event after acute myocardial infarction (AMI) in the elderly. It is unclear whether the risk of stroke after AMI has changed with improvements in treatments and outcomes for AMI in the last decade.

Methods

To assess trends in risk of stroke after AMI, we used a national sample of Medicare data to identify Fee-for-Service patients (n = 2,305,441) aged ≥65 years who were discharged alive after hospitalization for AMI from 1999 to 2010.

Results

We identified 57,848 subsequent hospitalizations for ischemic stroke and 4,412 hospitalizations for hemorrhagic stroke within 1 year after AMI. The 1-year rate of ischemic stroke decreased from 3.4% (95% CI 3.3%-3.4%) to 2.6% (2.5%-2.7%; P < .001). The risk-adjusted annual decline was 3% (hazard ratio, 0.97; [0.97-0.98]) and was similar across all age and sex-race groups. The rate of hemorrhagic stroke remained stable at 0.2% and did not differ by subgroups. The 30-day mortality for patients admitted with ischemic stroke after AMI decreased from 19.9% (18.8%-20.9%) to 18.3% (17.1%-19.6%) and from 48.3% (43.0%-53.6%) to 45.7% (40.3%-51.2%) for those admitted with hemorrhagic stroke. We observed a decrease in 1-year mortality from 37.8% (36.5%-39.1%) to 35.3% (33.8%-36.8%) for ischemic stroke and from 66.6% (61.4%-71.5%) to 60.6% (55.1%-65.9%) for hemorrhagic stroke.

Conclusions

From 1999 to 2010, the 1-year risk for ischemic stroke after AMI declined, whereas the risk of hemorrhagic stroke remained unchanged. However, 30-day and 1-year mortality continued to be high.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2014  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 169 - N° 1

P. 78 - Gennaio 2015 Ritorno al numero
Articolo precedente Articolo precedente
  • Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial
  • Ming Kai Lam, Hanim Sen, K. Gert van Houwelingen, Marije M. Löwik, Liefke C. van der Heijden, Marlies M. Kok, Frits H.A.F. de Man, Gerard C.M. Linssen, Kenneth Tandjung, Carine J.M. Doggen, Clemens von Birgelen
| Articolo seguente Articolo seguente
  • Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: An analysis of Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI)
  • Matthew I. Tomey, Roxana Mehran, Sorin J. Brener, Akiko Maehara, Bernhard Witzenbichler, José M. Dizon, Magdi El-Omar, Ke Xu, C. Michael Gibson, Gregg W. Stone

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.